Anthony Dyer - Love Hemp Director CFO
Insider
Anthony Dyer is Director CFO of Love Hemp Group
| Phone | 44 2039 785 322 |
| Web | https://www.worldhighlife.uk |
Love Hemp Management Efficiency
The company has return on total asset (ROA) of (0.6601) % which means that it has lost $0.6601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.3021) %, meaning that it generated substantial loss on money invested by shareholders. Love Hemp's management efficiency ratios could be used to measure how well Love Hemp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| OriMoni Mimon | INC Research Holdings | 36 | |
| Erica CPA | Biofrontera | 39 | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Sibyl Swift | cbdMD Inc | 43 | |
| Rami Levy | INC Research Holdings | 59 | |
| Hermann Lubbert | Biofrontera | 68 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| David Erickson | Evolus Inc | N/A | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Tejinder Virk | Akanda Corp | 42 | |
| John Weston | cbdMD Inc | N/A | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Sandra Beaver | Evolus Inc | 46 | |
| Amos Cohen | INC Research Holdings | 45 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| Matthew Coapman | cbdMD Inc | 48 | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| Eugene III | Biofrontera | 39 | |
| BCom BAcc | Akanda Corp | 44 | |
| Jeff Holm | Biofrontera | N/A | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
Management Performance
| Return On Equity | -3.3 | |||
| Return On Asset | -0.66 |
Love Hemp Group Leadership Team
Elected by the shareholders, the Love Hemp's board of directors comprises two types of representatives: Love Hemp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Love. The board's role is to monitor Love Hemp's management team and ensure that shareholders' interests are well served. Love Hemp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Love Hemp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Martin, Chief Officer | ||
| Stephen White, Chief Officer | ||
| Ian Munzberger, Chief Officer | ||
| Anna Legge, Chief Officer | ||
| Antonio Calamita, CEO Founder | ||
| Steve Horan, Head Marketing | ||
| Adam Pritchard, Chief Officer | ||
| Anthony Dyer, Director CFO | ||
| Martin Healy, Chief Officer |
Love Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Love Hemp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.3 | |||
| Return On Asset | -0.66 | |||
| Profit Margin | (2.25) % | |||
| Operating Margin | (2.24) % | |||
| Current Valuation | 2.51 M | |||
| Shares Outstanding | 829.15 M | |||
| Shares Owned By Insiders | 24.14 % | |||
| Shares Owned By Institutions | 0.12 % | |||
| Price To Book | 0.09 X | |||
| Price To Sales | 0.99 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Love Pink Sheet
Love Hemp financial ratios help investors to determine whether Love Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Love with respect to the benefits of owning Love Hemp security.